This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Budgets fail for avoidable reasons. Identify root causes and apply practical fixes to create a sustainable, effective budgeting routine.
28,657 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
A countywide fraud-prevention pilot is introducing a half-sheet questionnaire for withdrawals of $5,000 or more. Lear...
A stock delivering a 7% dividend yield and yet slipping 20% year-to-date may seem puzzling. This guide explains how t...
The Trade Desk prepares to report quarterly results as investors grapple with a steep stock drop, focusing on revenue...
A new working paper finds cfos admit privately that AI-related layoffs will rise ninefold this year, yet the total re...
Chevron's CEO warns that jet fuel shortages may push aviation costs higher as carriers trim schedules and consumers f...
Investors and households are bracing for the Federal Reserve's policy decision, with potential moves on borrowing cos...
Meta CEO Mark Zuckerberg faced lawmakers over under-13 Instagram use and the effectiveness of age checks. The session...
Fiserv announced the resignation of fiserv president dhivya suryadevara after less than a month in the role, with int...
In March 2026, investors seek cost-efficient, user-friendly options beyond M1 Finance. This report breaks down the to...
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...